Skip to main content
. Author manuscript; available in PMC: 2009 Aug 3.
Published in final edited form as: Int J Biostat. 2007;3(1):14. doi: 10.2202/1557-4679.1072

Table 4.

Strength of the instrument in subgroups defined by observed risk factors

Variable Instrument Strength 95% CI
U* E[X|U* = 1, Z = 1]
E[X|U* = 1, Z = 0]
Patient Characteristics
Full Population 22.8% 21.8 – 23.8%
Female Gender 22.1% 23.6 – 28.8%
Age ≥ 75 23.1% 21.9 – 24.2%
History of GI Bleed 18.2% 10.3 – 26.2%
History of Peptic Ulcer Disease 18.9% 13.5 – 24.3%
History of Coronary Procedure or Hospitalization 22.6% 20.0 – 20.5%
Recent/Concomitant Medications
Concomitant Use of a GI Protective Drugs 18.7% 14.1 – 23.2%
History of GI Protective Drug Use 20.1% 18.1 – 22.0%
Recent Use of Glucocorticoids 19.7% 16.2 – 23.2%
Recent Use of Warfarin 14.9% 12.1 – 17.7%